These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

222 related articles for article (PubMed ID: 36461035)

  • 1. Effects of Kami Guibi-tang in patients with mild cognitive impairment: study protocol for a phase III, randomized, double-blind, and placebo-controlled trial.
    Shin HY; Yim TB; Heo HM; Jahng GH; Kwon S; Cho SY; Park SU; Jung WS; Moon SK; Ko CN; Park JM
    BMC Complement Med Ther; 2022 Dec; 22(1):318. PubMed ID: 36461035
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Efficacy and safety of Kami-guibi-tang for mild cognitive impairment: a pilot, randomized, double-blind, placebo-controlled trial.
    Shin HY; Kim HR; Jahng GH; Jin C; Kwon S; Cho SY; Park SU; Jung WS; Moon SK; Ko CN; Park JM
    BMC Complement Med Ther; 2021 Oct; 21(1):251. PubMed ID: 34620151
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The effectiveness and safety of Kami Guibi-tang for mild cognitive impairment: study protocol of a pilot, randomized, placebo-controlled, double-blind trial.
    Shin HY; Kim JH; Jahng GH; Jung WS; Park SU; Ko CN; Park JM
    Trials; 2019 Jul; 20(1):448. PubMed ID: 31331367
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Efficacy of Kami Guibi-tang as an Add-On Therapy to Acetylcholinesterase Inhibitor for Cognitive Function in Mild Alzheimer's Disease: A Pilot Study.
    Kim HR; Shin HY; Yim TB; Jahng GH; Jin C; Kwon S; Cho SY; Park SU; Jung WS; Moon SK; Ko CN; Park JM
    Evid Based Complement Alternat Med; 2023; 2023():4846770. PubMed ID: 36756039
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of Kami Guibi-tang (KGT) in elderly subjects with insomnia: a study protocol from a single center, randomized, double-blind, placebo-controlled trial.
    Lee KH; Lee HG; Kwon S; Park SU; Jung WS; Moon SK; Park JM; Ko CN; Cho SY
    BMC Complement Med Ther; 2023 Oct; 23(1):375. PubMed ID: 37872506
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Treatment evaluation of Kami Guibi-tang on participants with amnestic mild cognitive impairment using magnetic resonance imaging on brain metabolites, gamma-aminobutyric acid, and cerebral blood flow.
    Cho SY; Kwon S; Shin HY; Kim HR; Kim JH; Park S; Ryu CW; Park JM; Edden RAE; Jahng GH
    J Appl Clin Med Phys; 2021 Nov; 22(11):151-164. PubMed ID: 34633758
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of acupuncture on episodic memory for amnesia-type mild cognitive impairment: study protocol of a multicenter, randomized, controlled trial.
    Dai Y; Xia R; Wang D; Li S; Yuan X; Li X; Liu J; Wang M; Kuang Y; Chen S
    BMC Complement Med Ther; 2023 Jul; 23(1):268. PubMed ID: 37507779
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effectiveness of Yi-Zhi-An-Shen granules on cognition and sleep quality in older adults with amnestic mild cognitive impairment: protocol for a randomized, double-blind, placebo-controlled trial.
    Yue S; He T; Li B; Qu Y; Peng H; Chen J; Lei M; Chen C; Wu W
    Trials; 2019 Aug; 20(1):518. PubMed ID: 31429790
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Safety and efficacy of Jujadokseo-hwan for memory deficit (amnesia) in mild neurocognitive disorder: A protocol for randomized, double-blind, placebo-controlled, parallel-group, multicenter clinical trial.
    Jeong JH; Lee JY; Kim JY; Seo YK; Kang WC; Kang HW; Park SJ; Jang HK; Park YC; Jung IC
    Medicine (Baltimore); 2020 Feb; 99(8):e19231. PubMed ID: 32080123
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A proof of concept phase II study with the PDE-4 inhibitor roflumilast in patients with mild cognitive impairment or mild Alzheimer's disease dementia (ROMEMA): study protocol of a double-blind, randomized, placebo-controlled, between-subjects trial.
    Possemis N; Verhey F; Prickaerts J; Blokland A; Ramakers I
    Trials; 2024 Mar; 25(1):162. PubMed ID: 38438923
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Study protocol for a randomised, double-blind, placebo-controlled 12-week pilot phase II trial of Sailuotong (SLT) for cognitive function in older adults with mild cognitive impairment.
    Steiner GZ; Bensoussan A; Liu J; Hohenberg MI; Chang DH
    Trials; 2018 Sep; 19(1):522. PubMed ID: 30253809
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cognitive improvement effects of Tian Wang Bu Xin Dan (Cheonwangbosimdan) in patients with mild cognitive impairment: protocol for a randomized placebo-controlled pilot clinical trial.
    Kim JH; Cho MR; Yoo J; Park GC; Lee JS
    Ann Palliat Med; 2022 Oct; 11(10):3320-3329. PubMed ID: 36267013
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of electroacupuncture combined with computer-based cognitive rehabilitation on mild cognitive impairment: study protocol for a pilot randomized controlled trial.
    Kim JH; Han JY; Park GC; Lee JS
    Trials; 2019 Aug; 20(1):478. PubMed ID: 31382998
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Combination of acupuncture and Chinese herbal formula for elderly adults with mild cognitive impairment: protocol for a randomized controlled trial.
    Chen Y; Zhang W; Wu H; Lao L; Xu J; Xu S
    Trials; 2019 Feb; 20(1):117. PubMed ID: 30744676
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Acupuncture for amnestic mild cognitive impairment: A pilot multicenter, randomized, parallel controlled trial.
    Zhang J; Kuang X; Tang C; Xu N; Xiao S; Xiao L; Wang S; Dong Y; Lu L; Zhang L
    Medicine (Baltimore); 2021 Nov; 100(46):e27686. PubMed ID: 34797294
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of cognitive training on episodic memory retrieval in amnestic mild cognitive impairment patients: study protocol for a clinical randomized controlled trial.
    Zhang K; Wang J; Peng G; Liu P; He F; Zhu Z; Luo B
    Trials; 2019 Jan; 20(1):26. PubMed ID: 30621794
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of Chinese medicine for tonifying the kidney and resolving phlegm and blood stasis in treating patients with amnestic mild cognitive impairment: a randomized, double-blind and parallel-controlled trial.
    Miao YC; Tian JZ; Shi J; Mao M
    Zhong Xi Yi Jie He Xue Bao; 2012 Apr; 10(4):390-7. PubMed ID: 22500712
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Efficacy and safety of So-Cheong-Ryong-Tang in patients with atopic dermatitis and respiratory disorders: Study protocol of a double-blind randomized placebo-controlled trial.
    Kang SJ; Cho HB; Jo EH; Yang GJ; Hong JE; Lee JH; Shim YH; Mun JH; Park MC
    Medicine (Baltimore); 2020 Jan; 99(2):e18565. PubMed ID: 31914034
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Neuroimaging basis in the conversion of aMCI patients with APOE-ε4 to AD: study protocol of a prospective diagnostic trial.
    Chen GQ; Sheng C; Li YX; Yu Y; Wang XN; Sun Y; Li HY; Li XY; Xie YY; Han Y
    BMC Neurol; 2016 May; 16():64. PubMed ID: 27176479
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Long-term efficacy of Chinese medicine Bushen Capsule on cognition and brain activity in patients with amnestic mild cognitive impairment.
    Zhang J; Yang C; Wei D; Li H; Leung EL; Deng Q; Liu Z; Fan XX; Zhang Z
    Pharmacol Res; 2019 Aug; 146():104319. PubMed ID: 31220560
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.